Recruiting
A Study of Mealtime Insulin LY900014 in Participants with Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
I8B-MC-ITSW - ClinicalTrials.gov - NCT04605991
This study is being done to evaluate glycemic control in participants with type 2 diabetes who are taking mealtime insulin LY900014 in combination with long-acting insulin glargine.
How long will I be in the trial?
The study will last about 19 weeks and may include up to 13 visits.
Recruiting
A Study of Mealtime Insulin LY900014 in Participants with Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
I8B-MC-ITSW - ClinicalTrials.gov - NCT04605991
This study is being done to evaluate glycemic control in participants with type 2 diabetes who are taking mealtime insulin LY900014 in combination with long-acting insulin glargine.
How long will I be in the trial?
The study will last about 19 weeks and may include up to 13 visits.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have a diagnosis of type 2 diabetes for at least 1 year
Participants must have already been treated with long-acting and mealtime insulins required for study participation
Participants blood glucose levels must be within allowed limits for study participation
Participants must NOT
Participants must not have had emergency treatment for very low blood glucose or very high blood glucose within the past 6 months
Participants must not be taking certain diabetes medications that are not allowed for study participation
Participants must not have major problems with their heart, kidney, liver, or have a blood disorder
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
LY900014
Could I receive a Placebo?
no
Enrollment Goal
167
Trial Dates
November 2020 - September 2021
Trial Phase
3
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have a diagnosis of type 2 diabetes for at least 1 year
Participants must have already been treated with long-acting and mealtime insulins required for study participation
Participants blood glucose levels must be within allowed limits for study participation
Participants must NOT
Participants must not have had emergency treatment for very low blood glucose or very high blood glucose within the past 6 months
Participants must not be taking certain diabetes medications that are not allowed for study participation
Participants must not have major problems with their heart, kidney, liver, or have a blood disorder
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
LY900014
Could I receive a Placebo?
no
Enrollment Goal
167
Trial Dates
November 2020 - September 2021
Trial Phase
3
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Adult Type 2 Diabetes Resources
